Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome
Phase of Trial: Phase II
Latest Information Update: 27 May 2017
At a glance
- Drugs Favipiravir (Primary)
- Indications Fever; Thrombocytopenia
- Focus Therapeutic Use
- 23 May 2017 Status changed from active, no longer recruiting to completed.
- 20 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 09 Jun 2016 New trial record